MARATTO

article · International Journal of Health Sciences

Characterization of skin tumors in an Egyptian large tertiary center

2024Open accessMansoura University

Abstract

Skin tumors are a global health problem caused by UV exposure with ethnic and geographical distribution. This research summarized Egyptian skin tumor features. A cross-sectional study was conducted in the Al-Hussein Teaching Hospital, Al-Azhar University, Cairo, Egypt. Patients’ data were collected from the hospital-recorded registry from January 2010 to December 2020. Results: The age group, 19-59y, showed the highest prevalence, 57% (n=940), of skin tumors. The total number of skin tumor patients was 1649 (males 52.9% (n=872), females 47.1% (n=777). For benign skin tumors, the male-to-female ratio was 1: 0.96, and for malignant skin tumors, the male-to-female ratio was 1: 1.47. The frequency of skin tumors at the sun-exposed site (out of the total n= 1770) was 39.4% (n= 697) and the face showed the highest frequency 25.8% (n=457). The frequency of skin tumors at the non-sun-exposed sites was 60.6% (n=1073) of the total skin tumor number. Basal cell carcinoma (BCC) showed a frequency of 90.1% of cases affecting sun-exposed sites. Therefore, skin tumors have unique characteristics in Egypt, with malignant skin tumors being rare showing more predilection in males. Further studies are needed to emphasize the national characteristics of skin tumors in Egypt.

Research topics

  • Cutaneous Melanoma Detection and Management

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.53730/ijhs.v8ns1.14936

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.